Skip to main content
Journal of Multimorbidity and Comorbidity logoLink to Journal of Multimorbidity and Comorbidity
. 2021 Jun 21;11:26335565211024791. doi: 10.1177/26335565211024791

Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey

Francisca Leiva-Fernández 1,2,3,, Alba González-Hevilla 1,2, Juan Daniel Prados-Torres 1,2,3, Fuensanta Casas-Galán 1,2, Eva García-Domingo 1,2, Paula Ortiz-Suárez 1,2, Juan Antonio López-Rodríguez 3,4,5, Maria Victoria Pico-Soler 3,6; MULTIPAP Group
PMCID: PMC8371279  PMID: 34422674

Background:

Current epidemiological situation has prompted the consideration of multimorbility (MM) as a prevalent condition, influenced by age, educational level and social support, related to unfavorable social and health determinants. Primary Care (PC) has a key role in its approach but further training of professionals in MM is required. The evidence on the effectiveness of training interventions in MM is still limited. Knowing the experiences, opinions and training needs of professionals is essential to enhance training interventions. Objectives: Identify perceived training needs by PC health professionals (doctors and nurses) in MM and polypharmacy. Methods: Design: Cross-sectional study based on an online survey (anonymous-ad hoc questionnaire). Participants and recruitment: 384 doctors and nurses working in healthcare centers and out-of-hospital emergencies of the Spanish National Health System. Non-probabilistic convenience sampling via email addressed to Health Institutions, and social networks. Data: Demographic characteristics and professional profile data (close-ended and multiple-choice questions) will be collected. Open-ended questions will be used to identify training needs, difficulties and resources about MM; required skills to care patients with MM will be assessed using a 4-item ordinal scale. Analysis: Coding of data prior to analysis. Descriptive statistical analysis, participation and completion rates of the questionnaire and estimation of absolute and relative frequencies and 95% confidence intervals in close-ended questions. Content analysis with inductive methodology in open-ended questions. Ethics: Ethical approval, Online informed consent. Conclusions: The identification of training needs of health professionals who care for patients with MM will be necessary data for developing highly effective training activities.

Keywords: Multimorbidity, polypharmacy, primary health care, learning, medical education

Introduction

Background and rationale

Multimorbidity (MM) is a phenomenon that has received considerable attention in recent years1 due to multiple factors, including demographic and epidemiological changes and the emergence of new clinical profiles and social and healthcare needs. Aging and the rising burden of chronic disease have created a shift in the distribution of disease and death to older ages and it leads to an expanding need and demand for care.25

The definitions of MM used in the scientific literature are numerous and diverse. Examples include the coexistence of two or more chronic diseases or chronic health conditions in the same individual,4 and the combination of a chronic condition with at least one other health condition (acute or chronic), whether physical, mental, developmental, psychosocial, or somatic.68 According to some authors, the latter definition excessively increases the prevalence of MM by including acute conditions, although it also takes into account fundamental determining factors.9 It has been demonstrated that there is a nonrandom association among chronic conditions, forming so-called MM patterns, suggesting the existence of common underlying pathophysiological mechanisms.5,10 However, groups of patients identified based on concurrent conditions and MM patterns can differ significantly in terms of sociodemographic, lifestyle, and clinical and functional profiles.11

The population prevalence of MM is as heterogeneous as the conceptual and methodological definitions applied and the characteristics of the studied population or data sources.12 Rates reported in the available literature range from 3.5% to 100%, depending on the age range and sample characteristics considered.13 Prevalence increases with age and is influenced by factors such as educational level, social support,1315 and continuity of care.16 In 2019, one of the largest systematic reviews of the global prevalence of MM conducted to date estimated a prevalence of 33.1%.17

MM has been associated with various negative consequences both for the individual and the health system. These include increased disability and functional deterioration1820 leading to poorer quality of life1921 and greater psychological distress,22 in addition to greater use of primary care (PC) services21,23 and increased hospital admissions.16,23,24 This in turn translates into a progressive increase in healthcare costs with each additional chronic disease.14,23,25,26

MM also predisposes affected individuals to polypharmacy (simultaneous treatment with more than 5 drugs) and the consumption of more drugs than clinically appropriate,27 with consequent risks of interactions, increased adverse effects, decreased therapeutic adherence, greater likelihood of inadequate prescribing, and even increased mortality.2831 For healthcare professionals, MM gives rise to many situations that complicate the management of polypharmacy: not knowing which medication to prioritize in a patient with multiple chronic diseases in which treatments overlap gives rise to uncertainty, and the widespread belief that chronic diseases require life-long treatment discourages making changes to patients’ medication regimens.32

Prescribing should be oriented towards the most important objectives for the patient (e.g. improving quality of life).33 However, the needs of patients do not always coincide with those perceived by health professionals. This causes discrepancies between the expectations of the health professional and those of the patient.34

The PC setting has an important role to play in the management of MM. In PC, medical and nursing professionals, which constitute the core of the patient’s care team at this level of care, must provide accessible, longitudinal, and comprehensive care. Furthermore, they must simultaneously manage multiple problems and acute and chronic conditions; coordinate and prioritize care with other health professionals; minimize iatrogenesis; and take into account the needs, lifestyle, preferences, and health priorities of each patient.35,36 This entails managing a large amount of clinical information, assessing the risks associated with polypharmacy and diagnostic procedures, and adapting treatment plans according to the patient’s circumstances.30,3440 Managing MM therefore represents a major challenge for PC health professionals, and is complicated by disorganization and fragmentation of the health system; the lack of institutional recognition of the leadership of the PC provider in comprehensive patient care; ineffective communication with other healthcare levels; limited time per consultation; traditional teaching methods based on specific diseases; inadequate clinical practice guidelines focused on individual diseases without considering combinations thereof; and difficulties implementing shared decision-making with patients and patient-centered care.638,4043 There is a need to identify, evaluate, and implement interventions that facilitate MM management using a comprehensive, community-supported approach and thereby improve the quality of life of these patients and reduce treatment burden, adverse events, and fragmented care, all of which are associated with increased healthcare utilization and costs.6,38,4447

A growing body of evidence supports the effectiveness of interventions for patients living with MM.13,44,45,4853 It is important to have a solid knowledge of the experiences, opinions, and learning needs54 of healthcare professionals in order to continue developing and evaluating these interventions and to ensure that participants receive the maximum practical benefits.44 The training of healthcare professionals, residents, and students of medicine and nursing has been based on traditional models of specific diseases and the establishment of a single diagnosis, rarely adjusting to the circumstances of the patient.32,38,39,42,43 A systematic review by Lewis et al.44 proposed relevant content for a curriculum that focuses more on MM, including skills in clinical practice, communication, critical evaluation, teamwork, information technology, and clinical management. This review emphasized the importance of identifying the training needs of individuals who will participate in the educational intervention so that they are adequately addressed in the different teaching objectives included in the intervention. These authors also suggested that initial assessment of training needs is essential for educators to offer practical, relevant, evidence-based, longitudinal, and indicator-oriented training that helps address the challenges posed by patients with MM, change practices, and improve clinical outcomes. Furthermore, identification of training needs is essential to ensure meaningful learning on the part of healthcare professionals.

However, formal needs assessments can be limited and can overlook important aspects in professions with high levels of unpredictability and uncertainty, resulting in a mismatch between the perceived training needs and the true knowledge gaps of the subject. Therefore, training should not focus exclusively on identified needs, nor should other more general learning be discouraged, even if it does not appear to address any specific training need.55 Moreover, assessments should not be limited to identifying the most appropriate training content, but should also determine which format is most acceptable among healthcare professionals and will have the greatest impact on clinical practice.44

The MULTIPAP study encompasses several projects, the first of which was a clinical trial56 evaluating a complex intervention that was based on the Ariadne Principles and targeted PC professionals,57 with a goal of improving the adequacy of prescribing in a population of young-old patients (65–74 years) with multimorbidity and polypharmacy. Part of this intervention consisted of an online course (eMULTIPAP) that has been proven effective in an analysis using Kirkpatrick’s 4-level evaluative model (evaluating the reaction, learning, behaviour, and results of the intervention). This analysis revealed improvements in the knowledge of the participating healthcare professionals and effective transfer of the acquired knowledge to healthcare practice, resulting in positive changes in patient health outcomes.58 To guide the design of the training content, an informal assessment of training needs was conducted among the facilitators (doctors and nurses with long-term experience in caring for patients with MM and polypharmacy). The objective of the present study was to use a broader, survey-based approach to identify the perceived training needs of a larger sample of PC medical and nursing professionals in the context of MM and polypharmacy.

Objectives

The primary objective of this study was to identify the training needs of PC medical and nursing professionals in the context of MM and polypharmacy.

The secondary objectives were as follows: (i) to explore differences in training needs in MM and polypharmacy between different professional profiles; (ii) to determine the preferred format of training material; (iii) to identify the main difficulties in caring for patients with MM and polypharmacy in PC; (iv) to determine which definition of MM is most endorsed by the respondents; (v) to evaluate the importance attributed by the respondents to the different skills proposed for the management of MM in daily clinical practice; (vi) to characterize the demographic and professional characteristics of the respondents; (vii) to compare the training needs identified by the respondents with the contents of the eMULTIPAP training activity. The flowchart in Figure 1 outlines the study design and the survey objectives.

Figure 1.

Figure 1.

Flow diagram and objectives of the research project.

Methods

The Checklist for Reporting Results of Internet E-Surveys (CHERRIES) will be used to guide the reporting of the study.59

Study design

Observational, descriptive, cross-sectional exploratory study based on an online survey.

This project is part of the MM research line of the MULTIPAP and MULTIPAP PLUS clinical trials, both of which received funding from the Health Research Fund of the Instituto de Salud Carlos III (ISCIII), and was co-financed with FEDER funding awarded to the MULTIPAP Study.

Eligibility criteria

PC doctors and nurses working in any of the autonomous communities of Spain in PC centers, emergency departments, or outpatient emergency services will be eligible for inclusion. All participants will be required to provide informed consent (IC) in order to participate in the online survey.

Participants will be selected through non-probability convenience sampling, without a specific sampling frame. Participants will be contacted by email, addressed to the health districts, health management areas, or equivalents of different autonomous communities in Spain, and via social networks (WhatsApp, Email, Twitter, and Facebook). The body of the email will include an invitation to participate in the survey, and will outline the eligibility criteria and provide access to the questionnaire once IC is provided.

Given the nature of data collection via online surveys, a low response rate and a potential selection bias are expected. Data available in the literature do not predict response rates higher than 40% in healthcare-related online surveys, and rates as low as 10% have been reported.60,61 For this reason, it is recommended to send a maximum of 3 monthly email reminders about the survey, and to leave open the possibility of mass dissemination of the survey by recipients through their own social networks (Facebook, Twitter, email, and/or instant messaging applications) in order to achieve greater participation and to reach the required sample size (Figure 1).

Survey methodology

The training needs of the participants will be explored through an online survey that has been prepared after a review of the literature on MM, training strategies for healthcare professionals, and online survey techniques to ensure maximum validity (Appendix 1).

The questionnaire, which is the basic instrument of our research, will be pilot tested on 10 healthcare professionals with characteristics similar to those of the target participants. They will be invited to answer the online survey, and to evaluate the clarity of the questions, if the order is adequate and to quantify the time taken to give all answers and the usability and technical functionality of the electronic questionnaire.

The questionnaire consists of 5 distinct sections: (i) sociodemographic and occupational characteristics of the participants; (ii) prior training in MM, opinions on the definition of MM, and previous involvement in any of the MULTIPAP Study projects; (iii) tools used to address challenges in caring for patients living with MM and importance attributed to a series of predefined skills to improve MM care; (iv) opinions on professional training needs; and (v) the preferred teaching method to address said training needs.

The electronic questionnaire was created using a free online tool (Google Form®), which provides an automated method of capturing survey responses in a spreadsheet format. The questionnaire is hosted on a website linked to an analytical tool (Google Sites® and Google Analytics®) in order to acquire the necessary metrics to determine the number of views and the survey completion rate and to identify unique users by IP (Internet Protocol) address. The questionnaire is anonymous, and email addresses are not collected; to avoid duplication of responses, the tool used to create the survey requires to log into a Google account, but in no way makes this information available to the survey creator. The average time required to answer the survey will be estimated in the pilot study. The survey consists of 2 pages: the first contains the IC form, completion of which is an essential requirement; and the second contains 32 items with closed questions and/or multiple-choice questions with a range of responses, with or without an open item, open questions, and questions with a 4-item ordinal scale. The repeated use of the same response options in the section of the questionnaire about tools used to care for patients with MM could give rise to invariable response bias. The short length of the questionnaire aims to minimize fatigue on the part of the respondent. Furthermore, the number of items has been kept even to eliminate neutral options. Finally, questions on similar topics will be randomly distributed throughout the questionnaire.62 The configuration of the questionnaire provides the respondent with the option of editing all answers up to the moment of submitting the completed questionnaire, and prevents return of an incomplete questionnaire. All received questionnaires will be analysed. Questionnaires will be sent to prospective participants 3 times on a monthly basis, via health institutions, in order to achieve the required sample size.

Outcome measures

Table 1 provides a summary of the study variables and the analytical methods.

Table 1.

Summary of outcomes, variables, measures and method of analysis.

Outcome Variable Measure/scoring Methods of analysis
Dissemination Receiving route
  • – Institutional email

  • – Non-institutional email

  • – Social networks

  • – Instant messaging

  • – Other

Per cent and frequencies for categories
Response rates View rate Number of total unique users who visit the first page of the survey, divided by the number of unique users who visit the website Per cent and frequency
Participation (Recruitment) rate Total number of unique users who complete the first page of the survey divided by the number of users who visit the first page of the survey Per cent and frequency
Completion rate Total number of people who return the completed last page of the questionnaire divided by the total number who agreed to participate Per cent and frequency
Sociodemographic characteristics and Job characteristics Province of origin Open answer Different answers will be listed as categories
Age Years completed by the respondent at the time of the survey Means, medians, SDs, range
Gender Male; Female; Other Per cent and frequencies for categories
Actual profession Doctor; Nurse
Years working in primary care* Numerical values Means, medians, SDs, range
Job currently held
  • – Primary Care Team

  • – Primary Care Emergency Service

  • – Both of them

  • – Hospital/out-of-hospital emergencies

  • – Other

Per cent and frequencies for categories
Workspace
  • – Rural

  • – Urban

  • – Both of them

Multimorbidity training and Participation in MULTIPAP Project
Multimorbidity training and participation in MULTIPAP Project (continued)
Specific training in multimorbidity Yes/no Per cent and frequencies for categories
Type of training received
  • – Classroom course

  • – Online course

  • – Unique talk or seminar

  • – Self-training

  • – Other (specify)

Training moment
  • – During last year

  • – Between 1–5 years

  • – > 5 years ago

Length of training period
  • – < 30 hours

  • – > 30 hours

Course contents
  • – Communication skills

  • – Clinical skills

  • – Management skills

  • – Critical assessment skills

  • – Teamwork

  • – Information technology skills

  • – Others (specify).

Definition of multimorbidity Open answer Answers will be read and reread by 2 researchers independently, with subsequent triangulation. Segmentation of quotes and generation of codes to establish thematic groupings or categories
Participation in MULTIPAP Project Yes/no Per cent and frequencies for categories
Training needs in multimorbidity (MM) Main difficulties and challenges in the care of patients with MM Open answer Per cent and frequencies for categories
Tools and resources used to face difficulties in caring for patients with MM Open answer Different answers will be listed as categories
Perception of the importance in the approach of multimorbidity in the clinical practice of 12 skills based on the curricular proposal of a recent systematic review on the subject 39
  • shared decision-making

  • time management

  • design care plans for complex patients

  • teamwork for continuity and coordination of care

  • support to patient and/or caregivers

  • management of pharmacological treatment

  • risk management

  • computer registration and information gathering

  • critical reading for research and problem solving

  • application and adaptation of guides

  • promote healthy and self-care lifestyles

  • patient-centered care

Per cent and frequencies for categories
Perceived training needs Perceived training needs in relation to the care of patients with MM and polypharmacy Open answer Different answers will be listed as categories
Course contents preferences
Desidered learning format Desired learning format
  • – Videos

  • – Texts

  • – Face-to-face courses

  • – Blended courses

  • – Online courses

  • – Others

Different answers will be listed as categories

MM: Multimorbidity; SD: Standard Deviation. Primary Care* includes: health centers, out of Hospital emergency and Primary Care Emergency Services.

The route through which the respondent receives the questionnaire will be recorded in each case. The view rate (number of total unique users who visit the first page of the survey, divided by the number of unique users who visit the website), the participation rate (total number of unique users who agreed to participate divided by the number of users who visit the first page of the survey), and the completion rate (total number of people who return the completed last page of the questionnaire divided by the total number who agreed to participate) will also be recorded.

Sociodemographic and work-related variables that will be recorded include province of origin, age and gender, profession (doctor, nurse), number of years working in PC, position held (health center team, emergency department, or both), and workplace location (rural, urban, or both).

Variables relating to prior training in MM will also be included to determine whether participants received any such training, the type and duration of the training activity, the curriculum content, and time elapsed since training. The definition of MM used by healthcare professionals will be assessed using a closed question with three proposed definitions, that corresponds to the most used ones from the WHO,4 the European General Practice Research Network7 and a systematic review by Fortin et al.63: (i) the combination of a chronic disease with at least one other acute or chronic health condition, whether physical, mental, developmental, or a psychosocial or somatic factor7; (ii) coexistence of two or more chronic health conditions in the same individual4; (iii) coexistence of three or more chronic health conditions in the same individual.63 This section also includes a dichotomous question about prior participation in the MULTIPAP Study.

Variables relating to the main difficulties identified in caring for patients with MM and the tools used by the respondents to address these difficulties are assessed through a series of open questions. The importance attributed to a series of predefined skills (established after literature review and discussion among researchers to reach consensus) to improve said care is measured using affirmative statements that the respondent is required to rate on an ordinal scale of 1 (“no importance”) to 4 (“maximum importance”). This part of the survey includes the following 12 skills: shared decision-making, time management, design of care plans for complex patients, teamwork for continuity and coordination of care, patient and/or caregiver communication and support, management of drug treatment, risk management, computerized records and information gathering, critical reading for research and problem solving, application and adaptation of clinical practice guidelines, communication and promotion of healthy lifestyles and self-care, and patient-centered care.

Finally, respondents are asked to state 3 training needs relating to the care of patients with MM and polypharmacy (open question), and about the contents (open question) and preferred format (videos, texts, in-person courses, blended courses, online courses, other) of training to address the identified needs.

Sample size

For the dichotomous questions, the required sample size, assuming maximum indeterminacy (p = 50%) with a confidence level of 95% and a precision of 5%, is 384 respondents.

For questions evaluated using a Likert scale, the required sample size was estimated following the method described by Rositas.64 According to the typical variances based on the number of points in the Likert scale (in this case 4 points), the mean tends to 2.5 and the variance in the uniform distribution tends to 1.3. Assuming a 95% confidence level, the final sample size is 104 respondents.

Based on these calculations, the final required sample size is 384 respondents. In the case of open questions, responses will be evaluated to determine whether saturation has occurred.

Analytical methods

Quantitative

Statistical analyses of the data will consist mainly of a descriptive analysis. For quantitative variables, measures of central tendency, position, and dispersion will be used. All data will be presented with 95% confidence intervals.

Bivariate analyses are proposed using tests appropriate to the data distribution. The Kolmogorov-Smirnov and Shapiro-Wilk tests will be used to verify the normality of the data. The Chi-squared test, analysis of variance (ANOVA), Kruskal-Wallis test, and Mann-Whitney U-test will be applied as appropriate depending on the distribution of the data.

Variables will be grouped into categories in order to perform a multivariate analysis, considering as dependent variables the definition of MM and the main skills needed to face the MM challenges. Age, gender, profession, job characteristics and previous training on MM characteristics will be considered as independent variables.

All analyses will be performed using SPSS software (version 22). Statistical significance will be established at p ≤ 0.05.

Qualitative

Responses to the open questions will be evaluated independently by two researchers through inductive analysis of the thematic content.65 Answers will be read and reread by two researchers independently, followed by segmentation of quotes and generation of codes to establish thematic groupings or categories, with subsequent triangulation, considering the concept of reflexivity, since the researcher is located within the research in continuous interaction with the data as a function of his or her previous experience and training. Responses that cannot be included in any of the established categories will be classified as “other responses.” Responses in this group will not exceed 5% of the total number of responses. Conflicts will be resolved by a third researcher.

Ethics

The study has been approved by the Research Ethics Committee of Malaga, and will be conducted in accordance with the principles established in the Declaration of Helsinki, the Council of Europe Convention on Human Rights and Biomedicine, and the requirements established in Spanish legislation. The study conforms to the norms of good clinical practice (art. 34 RD 223/2004; Community Directive 2001/20/CE) and the provisions of Regulation 2016/679 of the European Parliament and of the Council of April 27, 2016 on Data Protection (GDPR). All participants must express their agreement to participate in the survey by providing IC before beginning the questionnaire (Appendix 1).

Discussion

This article describes the design of an exploratory and descriptive study using an online survey of PC medicine and nursing professionals to identify perceived training needs, difficulties encountered, and available tools in the context of MM and polypharmacy.

The increase in the prevalence of MM and its impact on patients, healthcare professionals, and health systems has spurred research seeking to better understand this problem. A series of MM research priorities have been recognized, including maximizing the benefits and limiting the risks of treating patients with MM, and organizing health systems to better manage these patients.66 In the clinical management of MM, training of health professionals should play an important role.

The manner in which health systems, clinical practice guidelines, and healthcare training and research are oriented around discrete diseases is commonly recognized as one of the primary problems in current approaches to managing MM. Consequently, professionals must deal with uncertainty, insecurity, conflicts, and scarce supporting evidence in a fragmented and hyper-specialized healthcare context, making shared decision-making difficult. Another complaint is that current consultation times in PC are insufficient to allow comprehensive management of multiple conditions and a lack of interprofessional coordination acts as a source of iatrogenesis and added uncertainty, in addition to negatively influencing the patient’s perception of their healthcare.57,66,67 However, PC professionals recognize that longitudinality and continuity in the relationship with patients is a useful tool that can help address the challenge of MM and facilitate the adaptation of diagnostic and therapeutic plans and shared decision-making processes. PC workers have also proposed a range of improvements, including better working links with pharmacists to improve medication revision and the need for more training and education in the management of MM and its consequences.65 While training deficits may appear to be one of the easiest aspects to address, in reality there is little evidence demonstrating how such training can be effectively provided to PC professionals in a manner applicable to the PC context.44,52,53,58

A systematic review published in 201644 identified 2 studies of sufficient quality on the education of doctors in MM. The first was a pilot program38 that consisted of a 2-h workshop for general practitioners (GPs) based on simulated clinical cases, in which a before-and-after analysis revealed an increase in knowledge about the definition and characteristics of MM, as well as greater confidence among GP trainees in their ability to clinically manage patients living with MM. This study did not evaluate the long-term impact of the workshop. The second68 described a workshop in which a large group of professionals were presented with up-to-date clinical evidence, and subsequently worked in small groups to establish diagnosis and treatment plans in various complex clinical settings involving patients living with MM. The results were compared with a control group and the authors found that immediately after the educational intervention the participants in the intervention group had more knowledge and greater confidence in their ability to solve clinical cases.

The PRIMUM study52 evaluated the effectiveness of a complex intervention aimed at improving the adequacy of prescribing in patients with MM. One of the components of the intervention was a 90–120-min instructive activity in which GPs conducted interviews with patients about problems related to medication, were provided with examples of clinical cases and recommendations on the management of polypharmacy, and used a computerized decision support system to optimize medication. The authors found no significant differences between the intervention and control groups, possibly due to the limited room for improvement; the patients included in the study had already received adequate prescriptions at the beginning of the study and reported good quality of life.

The recently published 3D randomized controlled trial50,53 consisted of a training activity with case-based discussions, demonstration of the model proposed by the project, reflection, and task completion prior to a complex intervention in which each patient underwent three different reviews every 6 months performed by a nurse, a pharmacist, and a doctor. This intervention did not result in any improvement in quality of life or other secondary variables such as perceived burden of disease or treatment, although it was associated with an improvement in the patients’ perception of the quality of their care as compared with standard practice in health centers in England and Scotland.

Similarly, within the framework of the MULTIPAP study, the 4-week, 4-module, online eMULTIPAP course,58 which is based on the Ariadne Principles, has demonstrated a significant improvement in knowledge among healthcare professionals and successful transfer of this knowledge to healthcare practice, resulting in better health outcomes in patients with MM and polypharmacy.

The ongoing SPPiRE study69 aims to reduce inappropriate prescribing and polypharmacy in patients with MM through an intervention that includes the training of GPs using videos hosted on the project website and structured reviews of pharmacological treatments.

Strengths and limitations

The present project has several strengths. Although previous studies have sought to identify the training needs of GPs,70 this study is the first to do so specifically in the context of MM and to include the opinion of PC nurses, since both doctors and nurses play fundamental roles in this healthcare context.

Another strength of the project is the use of open questions, which provide a large amount of information and give complete freedom to the respondent. However, a limitation of this approach is that it also increases the effort required on the part of the respondent and the complexity of subsequent coding of the response. The number of open questions was limited in order to minimize these drawbacks.

To ensure rapid, cost-effective participation, the questionnaire will be disseminated online in an anonymous manner, and therefore the professional profile of the respondents could not be externally validated. This limitation could be addressed by also disseminating the questionnaire via professional networks. The use of a non-probabilistic sampling method for the sake of convenience may also result in a lack of representativeness of the study sample. However, although responses will be obtained from different geographic areas, the homogeneity of the healthcare model throughout most of the Spanish state means that the information obtained can be considered valid.

Professionals who decide to participate in the survey may be more interested in the subject and therefore have more training in the aspects evaluated in the questionnaire, thereby reducing the identification of training needs or very specific needs. Moreover, the fact that the survey is received and completed electronically may skew the respondent profile towards those with more technological skills and interests. The mandatory use of Gmail to complete the survey excludes professionals without a Gmail account, but enables the avoidance of bias due to duplicate responses. To minimize these limitations, the health districts and/or equivalent entities will be asked to disseminate the questionnaire electronically among all medical and nursing professionals in their area, and completion of the questionnaire will be as intuitive as possible and facilitated by the addition of an explanatory text (Appendix 2).

Implications for research

The identification of the MM training needs of the target population, as well as the preferred learning modality, will be taken into account when developing, refining, optimizing, modifying, and adapting interventions, which will consist of activities or a combination of elements designed to improve health outcomes.71 Likewise, identifying barriers, appropriately selecting the components of the intervention, and involving the participants are fundamental aspects of the design of interventions to generate change.72 After implementation of the teaching intervention, its effects can be evaluated through a structured procedure such as the Kirkpatrick’s model,73 which assesses four levels (reaction of the participants to the training activity; learning or acquisition of knowledge; changes in behaviour and application of the knowledge acquired in a clinical setting; and results of the training program).

Adequate planning and development of interventions to train healthcare professionals is essential to ensure success and translation into quality clinical care and better health outcomes for patients living with MM.

Implications for practice and policy

Caring for patients who have multiple pathologies and are being followed up by other specialists poses major challenges to doctors and nurses in terms of minimizing iatrogenesis, prioritizing the patient’s preferences, and emphasizing the importance of adherence to prescribed medications. Failure to adequately perform these tasks can lead to avoidable side effects, loss of pharmacological efficacy, the addition of unnecessary treatments, and poorer therapeutic adherence. This in turn contributes to poorer control of chronic diseases, with consequent increases in the number of hospital readmissions and negative effects on healthcare spending. It is therefore crucial to improve the doctor–patient relationship by creating a bond of trust and harmony that favours patient-centered care and shared decision-making, and to optimize patient care management to control avoidable admissions and readmissions and reduce mortality and healthcare costs. These goals can be pursued through the optimization of educational plans and reinforcement of the training of health professionals in the field of MM.

Training healthcare professionals in the multiple aspects of MM management and designing appropriate educational interventions integrated into healthcare practice are crucial goals, the achievement of which can be greatly facilitated by delving into the experience of PC professionals in this area, and more specifically the deficits they perceive. Designing training programs in response to identified needs helps to address real challenges and make learning more effective.44,68

Conclusions

Patients living with MM pose multiple challenges to the healthcare professionals who care for them. The identification of perceived training needs, as well as recognized difficulties and tools available to professionals who manage these patients on a daily basis must be considered in order to develop efficient training interventions, which can ultimately aid the creation of a patient-centered healthcare model that also translates into better clinical outcomes. The online, nationally disseminated survey proposed here seeks to obtain relevant quantitative and qualitative information from medical and nursing professionals working regularly in PC in Spain.

Supplemental material

Supplemental Material, sj-doc-1-cob-10.1177_26335565211024791 - Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey

Supplemental Material, sj-doc-1-cob-10.1177_26335565211024791 for Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey by Francisca Leiva-Fernández, Alba González-Hevilla, Juan Daniel Prados-Torres, Fuensanta Casas-Galán, Eva García-Domingo, Paula Ortiz-Suárez, Juan Antonio López-Rodríguez, Maria Victoria Pico-Soler and MULTIPAP Group in Journal of Comorbidity

Supplemental Material, sj-docx-1-cob-10.1177_26335565211024791 - Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey

Supplemental Material, sj-docx-1-cob-10.1177_26335565211024791 for Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey by Francisca Leiva-Fernández, Alba González-Hevilla, Juan Daniel Prados-Torres, Fuensanta Casas-Galán, Eva García-Domingo, Paula Ortiz-Suárez, Juan Antonio López-Rodríguez, Maria Victoria Pico-Soler and MULTIPAP Group in Journal of Comorbidity

Footnotes

Authors’ note: MULTIPAP GROUP:

Alexandra Prados-Torres (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain; Health Services and Chronic conditions Research Network (REDISSEC), Health Institute Carlos III, Madrid, Spain), Isabel Del-Cura-González (Research Unit. Primary Health Care Management of Madrid, Madrid Health Service, Spain, Public Health and Preventive Medicine Area, University Rey Juan Carlos, Madrid, Spain, Health Services and Chronic conditions Research Network (REDISSEC)), Christiane Muth (Senior Researcher, Head of Clinical Decision Unit, Faculty of Medical Science and Clinic, Institute of General Practice, Frankfurt am Main, Germany), Beatriz Poblador Plou (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain; Health Services and Chronic conditions Research Network (REDISSEC), Health Institute Carlos III, Madrid, Spain), Paula Ara-Bardají (Aragonese Institute of Health Sciences (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain), Mercedes Aza-Pascual-Salcedo (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Aragon Health Service (SALUD), Zaragoza, Spain), Antonio Gimeno-Miguel (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Miguel Servet University Hospital, Zaragoza, Spain), Luis Andrés Gimeno-Feliu (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.)Francisca González Rubio (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, PCHC Delicias Sur, Aragon Health Service (SALUD), Zaragoza, Spain), Cristina M Lozano Hernández (Research unit. Primary Health Care Management Madrid. Spain), María Eloisa Rogero-Blanco (Primary Care Health Centre General Ricardos, Madrid Health Service, Spain), Alessandra Marengoni (Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy), Jesús Martín Fernández (Multiprofessional Teaching Unit for Family and Community Care Primary Care PCHC Oeste, Madrid, Spain), Elena Polentinos Castro (Research unit. Primary Health Care Management Madrid. Spain), José María Valderas Martínez (University of Exeter Medical School, Exeter, UK. 22Department), María José Bujalance-Zafra (Teaching Unit for Family and community Primary Care Health District Málaga/Guadalhorce, Andalusian Health Service, Málaga, Spain, Biomedical Research Institute of Málaga –IBIMA-, University of Malaga, Spain), Marcos Castillo-Jimena (Teaching Unit for Family and community Primary Care Health District Málaga/Guadalhorce, Andalusian Health Service, Málaga, Spain, Biomedical Research Institute of Málaga –IBIMA-, University of Malaga, Spain) Maria del Pilar Barnestein-Fonseca (CUDECA Foundation, Biomedical Research Institute of Málaga –IBIMA-, Malaga University, Spain), Fernando López-Verde (Teaching Unit for Family and Community Primary Care Health District Málaga/Guadalhorce, Andalusian Health Service, Málaga, Spain), Miguel Domínguez-Santaella (PCHC Victoria, Malaga-Guadalhorce Health District, Andalusian Health Service, Malaga, Spain), Nuria García-Agua-Soler (Department of Pharmacology, Faculty of Medicine, Malaga University, Spain), María Isabel Márquez-Chamizo (PCHC Carranque, Malaga-Guadalhorce Health District, Andalusian Health Service, Málaga, Spain), José María Ruiz-San-Basilio (PCHC Churriana, Malaga-Guadalhorce Health District, Andalusian Health Service, Málaga, Spain), María Teresa Martínez-Cañavate (IAVANTE: Línea de Formación de la Fundación Progreso y Salud. Junta de Andalucía. Spain), José María Abad-Díez (Department of Health, Social Welfare and Family, Government of Aragon), Marta Alcaraz Borrajo (Subdirectorate General of Pharmacy and Health Products), Gloria Ariza Cardiel (Multiprofessional Teaching Unit for Family and Community Care Primary Care PCHC Oeste, Madrid, Spain), Amaya Azcoaga Lorenzo (PCHC Pintores, Madrid, Spain), José María Abad-Díez (Aragon Health Service (SALUD), Government of Aragon, Zaragoza, Spain), Marta Alcaraz Borrajo (Subdirectorate General of Pharmacy and Health Products), Ana Cristina Bandrés-Liso (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Aragon Health Service (SALUD), Zaragoza, Spain), Amaia Calderon-Larrañaga (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Zaragoza, Spain, Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm University, Stockholm, Sweden) Mercedes Clerencia-Sierra (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Miguel Servet University Hospital, Aragon Health Service (SALUD), Zaragoza, Spain), Javier Marta-Moreno (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Miguel Servet University Hospital, Aragon Health Service (SALUD), Zaragoza, Spain), Antonio Poncel-Falcó (EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, REDISSEC ISCIII, Aragon Health Service, Zaragoza, Spain), Ana Isabel González González (Technical Support Unit, Primary Care Management, Madrid Health Service), Virginia Hernández Santiago (Ninewells Hospital & Medical School, Dundee, UK), Angel Mataix SanJuan (Subdirectorate General of Pharmacy and Health Products, Madrid, Spain), Ricardo Rodríguez Barrientos (Research unit. Primary Health Care Management, Madrid, Spain), Mercedes Rumayor Zarzuelo (Public Health Centre Coslada, Área II Subdirectorate of Prevention and Health Promotion, Madrid, Spain), Luis Sánchez Perruca (General System Information Management, Primary Healthcare Management, Madrid Health Service, Spain), Teresa Sanz Cuesta (Research unit. Primary Health Care Management Madrid. Spain), Maria Eugenia Tello Bernabé (PCHC El Naranjo, Madrid, Spain).

Clinical Investigators in Primary Care Health Centres (PCHC):

(Andalucía, Spain): PCHC Alhaurín el Grande (Alhaurin el Grande): Javier Martín Izquierdo, Macarena Toro Sainz. PCHC Carranque (Málaga): María José Fernández Jiménez, Esperanza Mora García, José Manuel Navarro Jiménez. PCHC Ciudad Jardín, (Málaga): Leovigildo Ginel Mendoza, Luz Pilar de la Mota Ybancos, Jaime Sasporte Genafo. PCHC Coín, (Málaga): María José Alcaide Rodríguez, Elena Barceló Garach, Beatriz Caffarena de Arteaga, María Dolores Gallego Parrilla, Catalina Sánchez Morales. PCHC Delicias, (Málaga): Maria del Mar Loubet Chasco, Irene Martínez Ríos, Elena Mateo Delgado. PCHC La Roca, (Málaga): Esther Martín Aurioles. PCHC Limonar, (Málaga): Sylvia Hazañas Ruiz. PCHC Palmilla, (Málaga): María Auxiliadora Nieves Muñoz Escalante. PCHC Puerta Blanca, (Málaga): Enrique Leonés Salido, Maria Antonia Máximo Torres, Maria Luisa Moya Rodríguez, María Encarnación Peláez Gálvez, José Manuel Ramírez Torres, Cristóbal Trillo Fernández. PCHC Tiro Pichón, (Málaga): Maria Dolores García Martínez Cañavate, Maria del Mar Gil Mellado, Maria Victoria Muñoz Pradilla. PCHC Vélez Sur (Vélez Málaga): Maria José Clavijo Peña, José Leiva Fernández, Virginia Castillo Romero. PCHC Vera, (Vera, Almería): Rubén Vázquez Alarcón. PCHC Victoria, (Málaga): Rafael Ángel Maqueda, Gloria Aycart Valdés, Ana Maria Fernández Vargas, Irene García, Antonia González Rodríguez, Maria Carmen Molina Mendaño, Juana Morales Naranjo, Francisco Serrano Guerra.

(Aragón, Spain): PCHC Alcorisa, (Alcorisa, Teruel): Carmen Sánchez Celaya del Pozo. PCHC Delicias Norte, (Zaragoza): José Ignacio Torrente Garrido, Concepción García Aranda, Marina Pinilla Lafuente, Ma Teresa Delgado Marroquín. PCHC Picarral, (Zaragoza): Ma José Gracia Molina, Javier Cuartero Bernal, Ma Victoria Asín Martín, Susana García Domínguez. PCHC Fuentes de Ebro, (Zaragoza): Carlos Bolea Gorbea. PCHC Valdefierro, (Zaragoza): Antonio Luis Oto Negre. PCHC Actur Norte, (Zaragoza): Eugenio Galve Royo, Ma Begoña Abadía Taira. PCHC Alcañiz, (Teruel): José Fernando Tomás Gutiérrez. PCHC Sagasta - Ruiseñores, (Zaragoza): José Porta Quintana, Valentina Martín Miguel, Esther Mateo de las Heras, Carmen Esteban Algora. PCHC Ejea (Ejea de los Caballeros, Zaragoza): Maria Teresa Martín Nasarre de Letosa, Elena Gascón del Prim, Noelia Sorinas Delgado, Maria Rosario Sanjuan Cortés. PCHC Canal Imperial - Venecia, (Zaragoza): Teodoro Corrales Sánchez. PCHC Canal Imperial - San José Sur, (Zaragoza): Eustaquio Dendarieta Lucas. PCHC Jaca (Jaca, Huesca): María del Pilar Mínguez Sorio. PCHC Santo Grial, (Huesca): Adolfo Cajal Marzal.

(Madrid, Spain): PCHC Mendiguchía Carriche (Leganés): Eduardo Díaz García, Juan Carlos García Álvarez, Francisca García De Blas González, Cristina Guisado Pérez, Alberto López García Franco, Maria Elisa Viñuela Benitez. PCHC El Greco (Getafe): Ana Ballarín González, Maria Isabel Ferrer Zapata, Esther Gómez Suarez, Fernanda Morales Ortiz, Lourdes Carolina Peláez Laguno, José Luis Quintana Gómez, Enrique Revilla Pascual. PCHC Cuzco (Fuenlabrada): M Ángeles Miguel Abanto. PCHC El Soto (Móstoles): Blanca Gutiérrez Teira, PCHC General Ricardos (Madrid): Francisco Ramón Abellán López, Carlos Casado Álvaro, Paulino Cubero González, Santiago Manuel Machín Hamalainen, Raquel Mateo Fernández, Cesar Sánchez Arce. PCHC Ibiza (Madrid): Jorge Olmedo Galindo. PCHC Las Américas (Parla): Claudia López Marcos, Soledad Lorenzo Borda, Juan Carlos Moreno Fernández, Belén Muñoz Gómez, Enrique Rodríguez De Mingo. PCHC Maria Ángeles López (Leganés): Juan Pedro Calvo Pascual, Margarita Gómez Barroso, Beatriz López Serrano, Maria Paloma Morso Peláez, Julio Sánchez Salvador, Jeannet Dolores Sánchez Yépez, Ana Sosa Alonso. PCHC Ma Jesús Hereza (Leganés): Maria del Mar Álvarez Villalba. PCHC Pavones (Madrid): Purificación Magán Tapia. PCHC Pedro Laín Entralgo (Alcorcón): María Angélica Fajardo Alcántara, Maria Canto De Hoyos Alonso, Maria Aránzazu Murciano Antón. PCHC Pintores (Parla): Manuel Antonio Alonso Pérez, Ricardo De Felipe Medina, Amaya Nuria López Laguna, Eva Martínez Cid De Rivera, Iliana Serrano Flores, Maria Jesús Sousa Rodríguez. PCHC Ramón y Cajal (Alcorcón): Maria Soledad Núñez Isabel, Jesús Ma Redondo Sánchez, Pedro Sánchez Llanos, Lourdes Visedo Campillo.

Author contributions: AGH, FLF, FCG, EFD and POS conceived and designed the study protocol and drafted the manuscript; JDPT, JALR and MVPS made important contributions to the manuscript. All authors read and approved the final manuscript and made relevant contributions to the final content. MULTIPAP GROUP: His members made important recommendations for the study protocol. They also reviewed and made contributions to the final manuscript.

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Institute of Health Carlos III (Grant Numbers PI15/00996), REDISSEC (Project Numbers RD12/0001/0012, RD16/0001/0005, and RD16/0001/0006) and the European Regional Development Fund (‘a way to build Europe’).The funders had no role in study design, data collection and analysis, or decision to publish.

ORCID iD: Francisca Leiva-Fernández Inline graphic https://orcid.org/0000-0001-6919-4817

Supplemental material: Supplemental material for this article is available online.

References

  • 1.Fernández-Niño JA, Bustos-Vázquez E, Bustos-Vázquez E. Multimorbilidad: bases conceptuales, modelos epidemiológicos y retos de su medición. Biomédica 2016; 36(2): 188. [DOI] [PubMed] [Google Scholar]
  • 2.Instituto Nacional de Estadística (INE).INEbase. Indicadores demográficos básicos. Últimos datos. [Internet]. http://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736177003&menu=ultiDatos&idp=1254735573002 (2017, accessed 19 October 2018).
  • 3.Davies SC, Winpenny E, Ball S, et al. For debate: a new wave in public health improvement. Lancet 2014; 384(9957): 1889–1895. [DOI] [PubMed] [Google Scholar]
  • 4.World Health Organization (WHO). The World Health Report 2008. Primary Health Care (Now More Than Ever). Geneva: WHO. World Health Organization, 2008. [Google Scholar]
  • 5.Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One 2012; 7(2): e32190. DOI: 10.1371/journal.pone.0032190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. NG56. London: NICE. https://www.nice.org.uk/guidance/ng56 (2016, accessed 5 April 2018). [Google Scholar]
  • 7.Le Reste JY, Nabbe P, Rivet C, et al. The European general practice research network presents the translations of its comprehensive definition of multimorbidity in family medicine in ten European languages. PLoS One 2015; 10(1): e0115796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Le Reste JY, Nabbe P, Lazic D, et al. How do general practitioners recognize the definition of multimorbidity? A European qualitative study. Eur J Gen Pract 2016; 22(3): 159–168. [DOI] [PubMed] [Google Scholar]
  • 9.Salive ME. Multimorbidity in older adults. Epidemiol Rev 2013; 35(1): 75–83. [DOI] [PubMed] [Google Scholar]
  • 10.Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, et al. Multimorbidity patterns: a systematic review. J Clin Epidemiol 2014; 67: 254–266. [DOI] [PubMed] [Google Scholar]
  • 11.Marengoni A, Roso-Llorach A, Vetrano DL, et al. Patterns of multimorbidity in a population-based cohort of older people: sociodemographic, lifestyle, clinical, and functional differences. J Gerontol A Biol Sci Med Sci 2020; 75(4): 798–805. [DOI] [PubMed] [Google Scholar]
  • 12.Gontijo S, Berbiche D, Vasiliadis H. Measuring multimorbidity in older adults: comparing different data sources. BMC Geriatr 2019; 19(1): 166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Xu X, Mishra G, Jones M.Evidence on multimorbidity from definition to intervention: an overview of systematic reviews. Ageing Res Rev 2017; 37: 53–68. [DOI] [PubMed] [Google Scholar]
  • 14.Orueta JF, García-Álvarez A, García-Goñi M, et al. Prevalence and costs of multimorbidity by deprivation levels in the Basque country: a population based study using health administrative databases. PLoS One 2014; 9(2): e89787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Schiøtz ML, Stockmarr A, Høst D, et al. Social disparities in the prevalence of multimorbidity—a register-based population study. BMC Public Health 2017; 17(1): 422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gruneir A, Bronskill SE, Maxwell CJ, et al. The association between multimorbidity and hospitalization is modified by individual demographics and physician continuity of care: a retrospective cohort study. BMC Health Serv Res 2016; 16(1): 154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nguyen H, Manolova G, Daskalopoulou C, et al. Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb 2019; 9: 2235042X19870934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bayliss EA, Steiner JF, Fernald DH, et al. Descriptions of barriers to self-care by persons with comorbid chronic diseases. Ann Fam Med 2003; 1(1): 15–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011; 10(4): 430–439. [DOI] [PubMed] [Google Scholar]
  • 20.Fortin M, Bravo G, Hudon C, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res 2006; 15(1): 83–91. [DOI] [PubMed] [Google Scholar]
  • 21.Prazeres F, Santiago L. Relationship between health-related quality of life, perceived family support and unmet health needs in adult patients with multimorbidity attending primary care in Portugal: a multicentre cross-sectional study. Health Qual Life Outcomes 2016; 14(1): 156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fortin M, Bravo G, Hudon C, et al. Psychological distress and multimorbidity in primary care. Ann Fam Med 2006; 4(5): 417–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Glynn LG, Valderas JM, Healy P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract 2011; 28(5): 516–523. [DOI] [PubMed] [Google Scholar]
  • 24.Wang HH, Wang JJ, Wong SY, et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China. BMC Med 2014; 12: 188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007; 22(suppl 3):391–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Steiner C, Friedman B. Hospital utilization, costs, and mortality for adults with multiple chronic conditions, nationwide inpatient sample, 2009. Prev Chronic Dis 2013; 10: 120292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Villafaina-Barroso A, Gavilán-Moral E. Polimedicación e inadecuación farmacológica: ¿dos caras de la misma moneda? Pharm Care Esp 2011; 13(1): 23–29. [Google Scholar]
  • 28.Tinetti ME, McAvay G, Trentalange M, et al. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ 2015; 351: h4984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hakkarainen KM, Hedna K, Petzold H. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions—a meta-analysis. PLoS One 2012; 7(3): e33236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gavilán-Moral E, Villafaina-Barroso A, Jiménez-De Gracia L. Polimedicación en personas mayores. AMF-semFYC 2012; 8(8): 426–433. [Google Scholar]
  • 31.Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract 2012; 62(605): e821–826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sinnott C, Mercer SW, Payne RA, et al. Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel. Implement Sci 2015; 10(1): 132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cahill P. Prescribing for patients with multimorbidity: aiming to tailor to patient-set goals. Br J Gen Pract 2015; 65(632): 114–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cottrell E, Yardley S.Lived experiences of multimorbidity: An interpretative meta-synthesis of patients’, general practitioners’ and trainees’ perceptions. Chronic Illn 2015; 11(4): 279–303. [DOI] [PubMed] [Google Scholar]
  • 35.Wonca Europe. The European definition of general practice / family medicine. Barcelona: WONCA Europe, 2011. [Google Scholar]
  • 36.Prados-Torres D, del Cura-González I, Prados-Torres A. Hacia un modelo de atención a la multimorbilidad en atención primaria. Aten Primaria 2017; 49(5): 261–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Prados-Torres A, del Cura-González I, Prados-Torres JD, et al. Multimorbilidad en medicina de familia y los principios Ariadne. Un enfoque centrado en la persona. Aten Primaria 2017; 49(5): 300–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Maguire S, Hanley K, Quinn K, et al. Teaching multimorbidity management to GP trainees: a pilot workshop. Educ Prim Care 2015; 26(6): 410–415. [DOI] [PubMed] [Google Scholar]
  • 39.Rushton CA, Green J, Jaarsma T, et al. The challenge of multimorbidity in nurse education: an international perspective. Nurse Educ Today 2015; 35(1): 288–292. [DOI] [PubMed] [Google Scholar]
  • 40.Prazeres F, Santiago L. The knowledge, awareness, and practices of portuguese general practitioners regarding multimorbidity and its management: qualitative perspectives from open-ended questions. Int J Environ Res Public Health 2016; 13(11): 1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sinnott C, Mc Hugh S, Browne J, et al. GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 2013; 3(9): e003610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yardley S, Cottrell E, Protheroe J. Understanding success and failure in multimorbidity: protocol for using realist synthesis to identify how social learning and workplace practices can be optimised. Syst Rev 2013; 2(1): 87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yardley S, Cottrell E, Rees E, et al. Modelling successful primary care for multimorbidity: a realist synthesis of successes and failures in concurrent learning and healthcare delivery. BMC Fam Pract 2015; 16(1): 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lewis C, Wallace E, Kyne L, et al. Training doctors to manage patients with multimorbidity: a systematic review. J Comorb 2016; 6(2): 85–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Morrin L, Britten J, Davachi S, et al. Alberta healthy living program—a model for successful integration of chronic disease management services. Can J Diabetes 2013; 37(4): 254–259. [DOI] [PubMed] [Google Scholar]
  • 46.Cano Pérez M, Castell-Alcalá M, Queipo-Matas R, et al. Utilización de servicios de atención primaria, atención especializada y consumo de medicamentos por la población de 65 años y más en la Comunidad de Madrid. Rev Esp Salud Publica 2016; 90(3): 1–11. [PubMed] [Google Scholar]
  • 47.O’Mahony D, Gallagher P, Lavan A. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging 2016; 11: 857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.McKenzie KJ, Pierce D, Gunn JM. A systematic review of motivational interviewing in healthcare: the potential of motivational interviewing to address the lifestyle factors relevant to multimorbidity. J Comorb 2015; 5: 162–174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Smith SM, Wallace E, O’Dowd T, et al. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev 2016; 3: CD006560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Salisbury C, Man MS, Bower P, et al. Management of multimorbidity using a patient-centred care model: a pragmatic claster-randomised trial of the 3D approach. Lancet 2018; 392(10141): 41–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Baker JM, Grant RW, Gopalan A. A systematic review of care management interventions targetin multimorbidity and high care utilization. BMC Health Serv Res 2018; 18(1): 65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Muth C, Uhlmann L, Haefeli WE, et al. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial. BMJ Open 2018; 8(2): e017740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Salisbury C, Man MS, Chaplin K, et al. A patient-centred intervention to improve the management of multimorbidity in general practice: the 3D RCT. Health Serv Deliv Res 2019; 7(5): 1–238. DOI: 10.3310/hsdr07050. [PubMed] [Google Scholar]
  • 54.Arànega S. De la detección de las necesidades de formación pedagógica a la elaboración de un plan de formación en la universidad. Colección Cuadernos de Docencia Universitaria 2013: 1–74. [Google Scholar]
  • 55.Grant J. Learning needs assessment: assessing the need. BMJ 2002; 324: 156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Prados-Torres A, Del Cura-González I, Prados-Torres D, et al. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). Implement Sci 2017; 12(1): 54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Muth C, van den Akker M, Blom JW, et al. The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med 2014; 12: 223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Leiva-Fernández F, Prados-Torres JD, Prados-Torres A, et al. Training primary care professionals in multimorbidity management: educational assessment of the eMULTIPAP course. Mech Ageing Dev 2020; 192: 111354. [DOI] [PubMed] [Google Scholar]
  • 59.López-Rodríguez JA. Declaración de la iniciativa CHERRIES: adaptación al castellano de directrices para la comunicación de resultados de cuestionarios y encuestas online. Aten Primaria 2019; 51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Perreten NA, Domínguez-Berjón MF, Astray-Mochales J, et al. Tasa de respuesta a tres estudios de opinión realizados mediante cuestionarios en línea en el ámbito sanitario. Gac Sanit 2012; 26(5): 477–479. [DOI] [PubMed] [Google Scholar]
  • 61.Utzet M, Martin U.Las encuestas online y la falsa ilusión de la n grande. A propósito de una encuesta sobre la eutanasia en profesionales médicos. Gac Sanit 2020; 34(5): 518–520. [DOI] [PubMed] [Google Scholar]
  • 62.Goodhue D, Loiacono E. Randomizing survey question order vs. grouping questions by construct: an empirical test of the impact on apparent reliabilities and links to related constructs. In: Proceedings of the 35th Hawaii International Conference on System Sciences, Big Island, HI, USA, 10 January, 2002. DOI: 10.1109/HICSS.2002.994385. [Google Scholar]
  • 63.Fortin M, Stewart M, Poitras ME, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Medicine 2012; 10: 142–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Rositas J. Los tamaños de las muestras en encuestas de las ciencias sociales y su repercusión en la generación del conocimiento. Innovaciones de Negocios 2014; 11(22): 235–268. [Google Scholar]
  • 65.Moser A, Korstjens I.Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. Eur J Gen Pract 2017; 24(1): 9–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.The Academy of Medical Sciences. Multimorbidity: a priority for global health research. London, UK: The Academy of Medical Sciences, 2018. https://acmedsci.ac.uk/policy/policy-projects/multimorbidity (2018, accessed 24 February 2020). [Google Scholar]
  • 67.Damarell RA, Morgan DD, Tieman JJ. General practitioner strategies for managing patients with multimorbidity: a systematic review and thematic synthesis of qualitative research. BMC Fam Pract 2020; 21(1): 131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Andolsek K, Rosenberg MT, Abdolrasulnia M, et al. Complex cases in primary care: report of a CME-certified series addressing patients with multiple comorbidities. Int J Clin Pr 2013; 67(9): 911–917. [DOI] [PubMed] [Google Scholar]
  • 69.Kyne K, McCarthy C, Kiely B, et al. Study protocol for a process evaluation of a cluster randomised controlled trial to reduce potentially inappropriate prescribing and polypharmacy in patients with multimorbidity in Irish Primary Care (SPPiRE). HRB Open Res 2020; 2: 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Dowling S, Last J, Finnegan H, et al. What are the current ‘top five’ perceived educational needs of Irish general practitioners? Ir J Med Sci 2020; 189(1): 381–388. [DOI] [PubMed] [Google Scholar]
  • 71.Colquhoun HL, Squire JE, Kolehmainen N, et al. Methods for designing interventions to change healthcare professionals’ behaviour: a systematic review. Implement Sci 2017; 12(1): 30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.O’Cathain A, Croot L, Sworn K, et al. Taxonomy of approaches to developing interventions to improve health: a systematic methods overview. Pilot Feasibility Stud 2019; 5: 41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Kirkpatrick J, Kirkpatrick W. An introduction to the New World Kirkpatrick Model [Internet]. Newnan: Kirkpatrick Partners, LLC, 2010-2019. http://www.kirkpatrickpartners.com/Portals/0/Resources/White%20Papers/Introduction%20to%20the%20Kirkpatrick%20New%20World%20Model.pdf (2019, accessed 2020). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material, sj-doc-1-cob-10.1177_26335565211024791 - Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey

Supplemental Material, sj-doc-1-cob-10.1177_26335565211024791 for Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey by Francisca Leiva-Fernández, Alba González-Hevilla, Juan Daniel Prados-Torres, Fuensanta Casas-Galán, Eva García-Domingo, Paula Ortiz-Suárez, Juan Antonio López-Rodríguez, Maria Victoria Pico-Soler and MULTIPAP Group in Journal of Comorbidity

Supplemental Material, sj-docx-1-cob-10.1177_26335565211024791 - Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey

Supplemental Material, sj-docx-1-cob-10.1177_26335565211024791 for Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey by Francisca Leiva-Fernández, Alba González-Hevilla, Juan Daniel Prados-Torres, Fuensanta Casas-Galán, Eva García-Domingo, Paula Ortiz-Suárez, Juan Antonio López-Rodríguez, Maria Victoria Pico-Soler and MULTIPAP Group in Journal of Comorbidity


Articles from Journal of Comorbidity are provided here courtesy of SAGE Publications

RESOURCES